Endometriosis: What a Pain It Is

Paolo Vercellini, P Vercellini
Seminars in reproductive endocrinology · 1997 · vol. 15(03) , pp. 251–261 · doi:10.1055/s-2008-1068755 · PMID:9383834 · W2071000286
review OA: closed CC0 ⤵ 102 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

The severity of endometriosis pain is determined less by the disease's extent and more by lesion characteristics, peripheral beta-endorphin production, and local biochemical/physical effects.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 ⓘ

This paper reviews why studies that correlate endometriosis stage with pain severity often disagree, proposing that particular lesion characteristics rather than overall disease extension drive pain. It contrasts metabolically active intraperitoneal implants associated with functional pain (e.g., dysmenorrhea) with infiltrating, nodular, fibrotic lesions associated with organic-type pain (e.g., deep dyspareunia), and notes that women with symptomatic endometriosis show reduced peripheral β-endorphin production compared with pain patients without the disease, while neuroendocrine modulation remains unclear. It further concludes that available evidence does not support psychiatric features as a cause of endometriosis vulnerability and that symptomatic patients’ psychological profiles do not differ from those with other pain conditions or normal pelvis findings. This paper is centrally about endometriosis—specifically, lesion characteristics and biochemical factors underlying pelvic pain phenotypes.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The contrasting findings obtained in the studies that have attempted to correlate the stage of endometriosis with severity of pain symptoms suggest that some specific characteristics of the lesions are more implicated in the genesis of pain than disease extension per se. Thus, fresh, metabolically active, intraperitoneal implants may cause functional pain symptoms such as dysmenorrhea, whereas infiltrating, nodular and fibrotic lesions are responsible for organic-type pain such as deep dyspareunia. Women with symptomatic endometriosis seem to have reduced peripheral beta-endorphin production in comparison with pain patients without the disease, although neuroendocrine modulation of pelvic nociceptive stimuli is far from clear. There is little evidence to support the notion that specific psychiatric features render some women more vulnerable to developing endometriosis, as results from investigations performed on women with asymptomatic lesions are very similar to normative data. Moreover, it appears that the psychological profile of symptomatic patients with the disease is no different from those with pain and a normal pelvis or other gynecological conditions. Consequently, the local biochemical and physical effects of lesions seem to be the most important factors in determining frequency and severity of symptoms.

My notes (saved in your browser only)

Condition tags

mesh:D004412mesh:D004414mesh:D004715endometriosisdysmenorrheadyspareunia

MeSH descriptors

Endometriosis Pain beta-Endorphin beta-Endorphin Dysmenorrhea Dyspareunia Endometriosis Endometriosis Female Genitalia, Female Genitalia, Female Humans Laparotomy Mood Disorders Mood Disorders Pain Pain Peritoneal Diseases Peritoneal Diseases Peritoneal Diseases

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:52.568893+00:00
License: CC0 · commercial use OK